In Vivo Detection of Cell Death in the Area at Risk in Acute Myocardial Infarction
Paul W.L. Thimister, MD, PhD1,
Leo Hofstra, MD, PhD2,
Ing Han Liem, MD1,
Hendrikus H. Boersma, PharmD3,
Gerrit Kemerink, PhD1,
Chris P.M. Reutelingsperger, PhD4,5 and
Guido A.K. Heidendal, MD1
1 Department of Nuclear Medicine, University Hospital Maastricht, Maastricht, The Netherlands
2 Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
3 Department of Clinical Pharmacy, University Hospital Maastricht, Maastricht, The Netherlands
4 Department of Biochemistry, University Hospital Maastricht, Maastricht, The Netherlands
5 Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands

View larger version (13K):
[in a new window]
|
FIGURE 1. Time line of study protocol. Numbers of patients studied are in parentheses.
|
|

View larger version (98K):
[in a new window]
|
FIGURE 2. (A) Area at risk: 99mTc-MIBI injected before reperfusion. Reconstructed myocardial images of patient 2 after injection of 99mTc-MIBI in cardiovascular emergency room. Short-axis images show anteroseptal defect; vertical long-axis images, anteroapical defect; and horizontal long-axis images, apicoseptal defect. (B) Detection of cell death: 99mTc-annexin A5 after reperfusion. Reconstructed myocardial images of patient 2, 15 h after injection of 99mTc-BTAP-anxA5. Short-axis images show increased activity anteroseptally; vertical long-axis images, anteroapical hot spot; and horizontal long-axis images, increased apicoseptal activity. (C) 99mTc-annexin A5 uptake in area at risk: combination of parts A and B. Left 2 columns show 99mTc-MIBI activity; right 2 columns, 99mTc-annexin A5. (D) Acute inferior MI of patient 5: combination of some reconstructed images of 99mTc-MIBI activity (left 2 columns) and 99mTc-annexin A5. ANT = anterior; INF = inferior; LA = long axis or left atrium; LAT = lateral; LV = left ventricle; RA = right atrium; RV = right ventricle; SEPT = septal; Vert = vertical; Horz = horizontal.
|
|

View larger version (13K):
[in a new window]
|
FIGURE 3. 99mTc-MIBI defects (n = 6) expressed as percentage of left ventricle both in acute phase and in subacute phase of MI.
|
|

View larger version (75K):
[in a new window]
|
FIGURE 4. Repeated studies of 1 patient. (A) Combination of acute 99mTc-MIBI and 99mTc-annexin A5 uptake in area at risk on day 1 in patient studied several times. 99mTc-MIBI defect in anteroseptal and apical region (left 2 columns) correlates well with 99mTc-annexin A5 activity (right 2 columns). (B) 99mTc-annexin A5 activity compared on days 1 and 4 of acute MI. 99mTc-annexin A5 activity is already reduced after 4 d (right 2 columns), compared with day 1 (left 2 columns). L indicates liver activity; s indicates spleen activity. (C) 201Tl images (right 2 columns) clearly show complete recovery of area at risk seen on 99mTc-MIBI scan as performed at onset of MI (left 2 columns). ANT = anterior; INF = inferior; LA = long axis or left atrium; LAT = lateral; LV = left ventricle; RA = right atrium; RV = right ventricle; SEPT = septal; Vert = vertical; Horz = horizontal.
|
|
Copyright © 2003 by the Society of Nuclear Medicine.